Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Neurology
Disease Category: Epilepsy
Trial Information
Epilepsy and non-controlled partial seizures
We are conducting a clinical research study for volunteers
diagnosed with Epilepsy with partial-onset seizures with or without
secondarily generalization. This study tests the effectiveness of
an investigational drug on total partial seizure frequency in
adolescent and adult patients 12 years and older taking a maximum
of three antiepileptic medications.
Study Criteria:
- Age 12-80
- Diagnosed with Epilepsy supported by a clinical history, EEG
and CT/MRI within the last 10 years
- Non-controlled partial seizures despite having been treated
with at least two different antiepileptic drugs for at least two
years.
- Must experience at least 6 seizures during a 56-day baseline
with no 21-day seizure free periods.
- Current treatment with a maximum of three approved
antiepileptic drugs and on a stable dose for one month prior to
screening.
- If using vagal nerve stimulator (VNS), it must have been
implanted for at least six months prior to randomization
- Cannot have a diagnosis of major active psychiatric disease
and/or attempted suicide within the previous 10 years
- Cannot have a progressive central nervous system (CNS) disease,
including degenerative CNS disease and progressive tumors
- No history of drug and/or alcohol
- Cannot frequently need rescue benzodiazepines (more than once a
month)
- No known hypersensitivity to rufinamide, triazole derivatives,
or to any excipients used in the formulation
If eligible, you will receive investigational drug and
study-related medical care at co cost. Travel and parking costs may
also be available.
For additional information about this study or to enroll, visit
our website:
www.clinicaltrialsinc.com
Clinical Trials, Inc.
Two Lile Court,
Suite 100
Little Rock, AR 72205
Phone: 501-227-6179
Fax: 501-221-3426
EMail: llanders@clinicaltrialsinc.com
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
